FURNERI, Pio Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.352
EU - Europa 3.691
AS - Asia 2.486
SA - Sud America 495
AF - Africa 181
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.218
Nazione #
US - Stati Uniti d'America 6.059
SG - Singapore 1.370
IT - Italia 1.271
CN - Cina 870
IE - Irlanda 833
UA - Ucraina 769
BR - Brasile 461
CA - Canada 270
RU - Federazione Russa 208
DE - Germania 128
SE - Svezia 109
CI - Costa d'Avorio 105
FR - Francia 88
GB - Regno Unito 72
IN - India 60
SN - Senegal 43
FI - Finlandia 41
VN - Vietnam 33
KR - Corea 30
PL - Polonia 25
CH - Svizzera 23
AT - Austria 22
NL - Olanda 22
CZ - Repubblica Ceca 19
UZ - Uzbekistan 18
GR - Grecia 16
TR - Turchia 16
AR - Argentina 15
ES - Italia 14
BD - Bangladesh 13
LB - Libano 11
MX - Messico 11
IR - Iran 10
PK - Pakistan 10
IQ - Iraq 8
ZA - Sudafrica 8
MA - Marocco 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
EU - Europa 6
JP - Giappone 6
AZ - Azerbaigian 5
DK - Danimarca 5
RE - Reunion 5
SA - Arabia Saudita 5
AU - Australia 4
BE - Belgio 4
HR - Croazia 4
KZ - Kazakistan 4
PA - Panama 4
EG - Egitto 3
JO - Giordania 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
LU - Lussemburgo 2
MK - Macedonia 2
NG - Nigeria 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DJ - Gibuti 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 13.218
Città #
Chandler 901
Santa Clara 879
Dublin 832
Singapore 801
Jacksonville 717
Chicago 424
Boardman 368
Catania 298
Nanjing 260
Cambridge 228
Lawrence 228
Andover 225
Toronto 211
Ashburn 188
San Mateo 148
Abidjan 105
Wilmington 103
Des Moines 101
Nanchang 79
Civitanova Marche 76
Hebei 72
Shenyang 68
Hefei 67
Palermo 49
Rome 47
Council Bluffs 46
Los Angeles 44
Ottawa 44
Saint Petersburg 44
Dakar 43
Tianjin 40
Changsha 39
São Paulo 39
Jiaxing 38
Munich 35
The Dalles 33
Beijing 32
Columbus 32
Houston 29
Seoul 29
Milan 28
Seattle 27
Messina 23
Bremen 22
Dong Ket 22
Norwalk 22
Naples 21
Padova 21
Washington 21
Falls Church 20
Pune 20
Jinan 19
Kochi 19
Misterbianco 19
Vicenza 19
Helsinki 18
Moscow 18
Mascalucia 17
Rio de Janeiro 17
Hangzhou 16
Lappeenranta 14
Milazzo 14
Lecce 13
Zhengzhou 13
Liberty Lake 12
New York 12
Viagrande 12
Belo Horizonte 11
Leawood 11
Phoenix 11
Ann Arbor 10
Augusta 10
Frankfurt am Main 10
Grafing 10
Kunming 10
Belpasso 9
Fortaleza 9
London 9
San Francisco 9
Scicli 9
Brasília 8
Bussero 8
Dallas 8
Den Haag 8
Hanoi 8
Istanbul 8
Amsterdam 7
Ardabil 7
Boston 7
Brno 7
Campinas 7
Frankfurt Am Main 7
Hanover 7
Mumbai 7
Polska 7
Porto Alegre 7
Aci Sant'antonio 6
Bologna 6
Bronte 6
Brooklyn 6
Totale 8.811
Nome #
Antiviral activity of clofoctol in vitro [ATTIVITA ANTIVIRALE 'IN VITRO' DELL'OCTOFENE] 135
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 133
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 114
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy 113
Biological properties and production of bacteriocins-like-inhibitory substances by Lactobacillus spp. strains from human vagina 113
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 111
ANALISI DELLA SEQUENZA DELLE REGIONI A MONTE DEI "PEPTIDE SEGNALE" E "RIBOSOMAL BINDING SEQUENCE" DEI GENI ERM(B) ED ERM(A) 110
Biological properties of itraconazole-SLN 105
Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin 103
Antimicrobial activity of nifuratel [ATTIVITA ANTIMICROBICA DEL NIFURATEL] 101
Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis 99
A method for efficient loading of ciprofloxacin hydrochloride in cationic solid lipid nanoparticles: Formulation and microbiological evaluation 93
SOLID LIPID NANOPARTICLES AS A STRATEGY TO IMPROVE THE IN VITRO ANTIMICROBIAL ACTIVITY OF ITRACONAZOLE 92
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 87
Formulation and characterization of erythromycin–loaded Solid Lipid Nanoparticles 87
Author Correction: Cytotoxicity, mutagenicity and genotoxicity of electronic cigarettes emission aerosols compared to cigarette smoke: the REPLICA project (vol 13, 17859 , 2023) 87
Anti-Adhesion Activity of A2-type Proanthocyanidins (a Cranberry Major Component) on Uropathogenic E. coli and P. mirabilis Strains 85
Assessment of preservative efficacy of sodium N-hydroxymethylglicinate (NIG) in drug delivery formulations for ophthalmic use 85
Bacterial symbionts of entomopathogenic nematodes of the genus Steinernema from South Italy: phenotypic features and evolutionary implications 84
Amensalistic Activity of Human Lactobacillus Strains Isolates 83
Role of heme oxygenase-1 (HSP32) and HSP90 in glioblastoma 81
Influenza dell’associazione clotrimazolo/metronidazolo (1:5) sullo “switching” fenotipico di C. albicans 80
"Dual-drug delivery in Solid Lipid Nanoparticles: preliminary studies" 80
Commentary: Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine 80
The Antimicrobial Activity of Essential Oils Against Multi-Drug-Resistance Microorganisms: A Review 79
Investigation on the antibacterial activity of electronic cigarette liquids (ECLs): a proof of concept study 79
Bacteriocins, a natural weapon against bacterial contamination for greater safety and preservation of food: a review 79
GenBank AF422141: Mycoplasma fermentans "incognitus strain" 23S rRNA gene, partial sequence of domain 1 78
Il Microbiota vaginale e le infezioni urogenitali 78
ANTI-MYCOPLASMAL ACTIVITY OF A NEW MACROLIDE - MIOCAMYCIN 77
Analysis and sequencing of the attenuator region of erm(A) gene in Streptococcus pyogenes strains with constitutive or inducible phenotype 77
Postbiotic Characterization in the Amensalistic Symbiosis and Correlation to the Resilience of Human Microbiota 77
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 75
Evaluation of resistance to low pH and bile salts of human Lactobacillus spp. isolates 75
Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily) 75
Biological properties of itraconazole-SLNs 75
A sustainable porous composite material based on loofah-halloysite for gas adsorption and drug delivery 73
Electronic cigarette vapour enhances pneumococcal adherence to airway epithelial cells under abnormal conditions of exposure 73
Metabolic Characterization of Supernatants Produced by Lactobacillus spp. With in vitro Anti-Legionella Activity 73
Biofilm Formation by Streptococcus agalactiae Human Isolated Strains 71
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 70
The impact of Prulifloxacin on vaginal lactobacillus microflora:an in vivo study 70
Pefloxacin mesilate and Ofloxacin-loaded polyethylcyanoacrylate nanoparticles. Characterization of the colloidal drug carrier formulation 70
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 70
GenBank AF131073: Mycoplasma hominis strain CT-PAF 23S ribosomal RNA gene, partial sequence 69
C. Trachomatis detection in infertile women by using a tubal cytobrush during laparoscopy 68
Econazole-polycarbophil, a new delivery system for topical therapy: microbiological and clinical results on vaginal candidiasis 68
SOME PHARMACOKINETIC DATA ON MIOCAMYCIN .1. SERUM, URINARY AND PROSTATIC LEVELS 68
New anti sars-cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine 68
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 67
Vaginal bacterial colonisation in post menopause: focus on uropathogenes 67
Analysis and Sequencing of the Regulatory Region of erm(B) in Streptococcus pyogenes Strains with “Peculiar” Inducible Phenotypes 67
EPIDEMIOLOGIC SURVEY OF MYCOPLASMA-PNEUMONIAE INFECTIONS - COMPARISON BETWEEN ELISA AND OTHER SEROLOGICAL TESTS 67
Assenza di penicillino resistenza in ceppi di Streptococcus agalactiae isolati in Sicilia 67
Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells 66
Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis 66
In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil 66
Antimicrobial nonapeptide leucinostatin A-dependent effects on the physical properties of phospholipid model membranes 66
Inhibitory effect of Melaleuca alternifolia (tea tree oil) on influenza A/PR/8 virus replication 66
Multicenter study on clinical-microbiological activity of ofloxacin in "community acquired" gynaecological infections. 65
Amphiphilic ion pairs of tobramycin with lipoamino acids 65
Amphiphilic erythromycin-lipoamino acid ion-pairs: characterization and in vitro microbiological evaluation 65
In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa 64
Evaluation of antinfective activity of an association bifidobacterium/lactobacillus in mouse intestine 64
Commentary: Lactobacilli dominance and vaginal pH: Why is the human vaginal microbiome unique? 64
Management of Aerobic Vaginitis 63
Nuove tecniche di analisi molecolare per l'identificazione delle comunità microbiche vaginali 63
In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis 63
SOME PHARMACOKINETIC DATA ON MIOCAMYCIN .2. CONCENTRATIONS IN GYNECOLOGICAL TISSUES 63
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 63
Analisi retrospettiva sulla sensibilità in vitro agli antibiotici del gruppo MLS in Streptococcus agalactiae daal 1994 al 2005 63
Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications 63
Intracellular accumulation of ofloxacin-loaded liposmes in human synovial fibroblasts 62
Anti-mycoplasmal activity of hydroxytyrosol 62
Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin 62
Colistin and Kanamycin Together in Association with Coridothymus capitatus to Enhance their Antimicrobial Activity and Fight Multidrug-Resistance Pathogens 62
Solid Dispersions of Chitosan Glutamate for the Local Delivery of Miconazole: Characterization and In Vitro Activity 61
Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook 61
Analisi e sequenziamento della regione regolatrice del gene erm(A) ad espressione costitutiva o inducibile 61
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects 61
In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components 60
Correlation between PRTF1-F2 and macrolide resistance in Streptococcus pyogenes 60
GenBank AF317663: Mycoplasma hominis strain PG21/JR2 23S ribosomal RNA gene, partial sequence 60
Probiotic Properties of Lactobacillus fermentum Strains Isolated from Human Oral Samples and Description of their Antibacterial Activity 60
Laparoscopy diagnosis of chlamydial salpingitis using a tubal cytobrush 60
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs 59
Biofilm Formation by Streptococcus agalactiae Human Isolated Strains 59
In vitro Antimycoplasmal Activity of Citrus bergamia Essential Oil and its Derivatives 59
GenBank EU492925: Streptococcus pyogenes strain 3-CT leader peptide 1 (lpg1) and leader peptide 2 lpg2) genes, complete cds; and erythromycin resistance methylase [erm(A)] gene, partial cds, 59
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 58
SEQUENZIAMENTO DEL GENOMA DI MYCOPLASMA HOMINIS: I. STRATEGIE PER IL CLONAGGIO E CREAZIONE DELLA BANCA COSMIDICA 58
Longitudinal study on the therapy of Mycoplasma pneumoniae infections with ciprofloxacin on Syrian hamsters 58
Lactobacillus rhamnosus AD3 as a promising alternative for probiotic products 58
Spiroplasma spp.: A Plant, Arthropod, Animal and Human Pathogen 57
VI-5. Dosaggio microbiologico degli antibiotici 57
Relationships between hydrophobicity and biofilm formation in Streptococcus agalactiae strains 57
"Fingerprinting" genomico: la DOP PCR 57
Correlation Between Virulence Factors and Macrolide Resistance in Streptococcus pyogenes 57
Isolamento della variante "B" del gene ermTR 57
Influence of Media and Incubation Conditions on Biofilm Formation by Streptococcus agalactiae Strains 57
Totale 7.328
Categoria #
all - tutte 51.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.462 41 154 165 111 409 47 122 16 114 4 193 86
2021/20221.751 212 271 12 38 266 21 247 59 176 11 76 362
2022/20232.691 244 109 42 258 287 503 15 401 652 38 96 46
2023/20241.109 90 140 56 66 55 210 9 55 15 27 233 153
2024/20254.532 51 849 288 209 869 373 159 244 326 480 298 386
2025/2026151 151 0 0 0 0 0 0 0 0 0 0 0
Totale 13.615